bicalutamide,apalutamide,abiraterone
janssen
['formula509']
 6m has no os benefit. what trial do you quote them? even formula509 showed, as we did with rtog 9601, benefit in higher psa pts (ie they have mets more likely)
Vincent Smith Professor and Chair of Radiation Oncology University Hospitals Seidman Cancer Center Case Western Reserve University SOM.  *TWEETS are my own*